KSK Diagnostics Overview

  • Founded
  • 2014
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

KSK Diagnostics General Information

Description

Developer of molecular point-of-care diagnostic assays designed to diagnose infectious diseases and cancer. The company's assays use isothermal amplification technology for patient-oriented diagnostics and are also suited to quickly clarify issues related to tumour diagnostics, enabling doctors to make a diagnosis after 30 minutes and coordinate the treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Primary Office
  • Tempowerkring 1
  • 21079 Hamburg
  • Germany
+49 040 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KSK Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2019 Completed Out of Business
2. Early Stage VC (Series A) 24-Apr-2017 Completed Startup
1. Grant $167K Completed Startup
To view KSK Diagnostics’s complete valuation and funding history, request access »

KSK Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Stefan Kulick Co-Founder & Managing Director
Guido Krupp Co-Founder
Peter Scheinert Co-Founder
To view KSK Diagnostics’s complete executive team members history, request access »